Ocata Therapeutics Inc (NASDAQ:OCAT)

6.34
Delayed Data
As of May 29
 -0.02 / -0.31%
Today’s Change
4.95
Today|||52-Week Range
12.73
+4.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-72.8M-28.5M-31.0M-34.7M
 
 
 
 
 
Depreciation67.2K58.6K93.5K173.1K
 
 
 
 
 
Total Other Cash Flow58.6M9.1M11.9M15.5M
 
 
 
 
 
Funds From Operations-14.1M-19.3M-19.0M-19.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-493.7K-4.7M3.0M2.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-13.6M-14.6M-22.0M-21.4M
 
 
 
 
 
 
InvestingCapital Expenditures-36.8K-96.3K-671.8K-263.4K
 
 
 
 
 
Other Investing - Uses0.00-15.1K-38.9K0.00
 
 
 
Net Cash Flow Investing-36.8K-111.4K-710.8K-263.4K
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.00----
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction--0.00-600.0K-1.2M
 
 
 
Net Proceeds Stock Sale10.9M8.9M17.8M25.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.0070.1K
 
 
Net Cash Flow - Financing10.9M8.9M17.2M24.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-2.8M-5.9M-5.5M2.7M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account